Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.

NCT03252808 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer Stage III
Pancreatic Cancer Stage IV

Interventions

BIOLOGICAL: TBI-1401(HF10)
DRUG: Gemcitabine
DRUG: Nab-paclitaxel
DRUG: TS-1

Sponsor

Takara Bio Inc.